OR WAIT null SECS
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
October 24, 2014
Johnson& Johnson is collaborating with WHO and others on clinical testing, development, production, and distribution of an Ebola vaccine.
October 23, 2014
Contract Packaging Resources issued a voluntary recall of naproxen sodium tablets because some cartons contain bottles of ibuprofen.
October 20, 2014
The agency recommends that companies developing drugs to treat Ebola apply for orphan drug designation.
October 15, 2014
PharmaSpray delivers a consistent, validatable amount of dry lubricant.
Manufacturers using highly potent APIs must examine cross-contamination routes and determine acceptable limits.
October 10, 2014
IDT Biologika completes large-scale biologics finishing facility in Dessau, Germany.
October 06, 2014
The total market for biopharmaceuticals in 2013 was $36.8 billion according to Kalorama Information. Meanwhile, Frost & Sullivan estimates that the biosimilars market, which it pegged at just $1.2 billion in 2013, will grow to $23 billion in 2019, or more than 20-fold increase.
Pharmaceutical Technology Europe spoke with Piero Iamartino, R&D director at Micro-Macinazione, about the role of micronization in pharmaceutical manufacturing.
The last 12 months have seen a number of major acquisitions in the contract manufacturing space.
October 03, 2014
LABOCHIM SpA completes construction on multipurpose high-potent API plant in Milan.